Mutations in TP53, ZNF750, and RB1 typify ocular sebaceous carcinoma

被引：5
|
作者：
Bao, Yongyang [1 ]
Selfridge, J. Eva [2 ,3 ,4 ]
Wang, Janet [3 ,4 ]
Zhao, Yiqing [3 ,4 ]
Cui, Junqi [1 ]
Guda, Kishore [3 ]
Wang, Zhenghe [3 ,4 ]
Zhu, Yanbo [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Pathol, Shanghai 200011, Peoples R China
[2] Univ Hosp Cleveland, Med Ctr, Seidman Canc Ctr, Cleveland, OH 44106 USA
[3] Case Comprehens Canc Ctr, Cleveland, OH 44106 USA
[4] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA
来源：
JOURNAL OF GENETICS AND GENOMICS | 2019年 / 46卷 / 06期
关键词：
SQUAMOUS-CELL CARCINOMA; TUMOR-SUPPRESSOR; P53; MUTATIONS; GENES; EXPRESSION; PROTEIN; KLF4;
D O I：
10.1016/j.jgg.2019.06.001
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：315 / 318
页数：4
相关论文
共 50 条
  • [31] Evaluating RB1 and p53 as diagnostic markers in treatment-related neuroendocrine prostate cancer through immunohistochemistry and genomic analysis of RB1 and TP53
    Ueki, Hideto
    Jimbo, Naoe
    Terakawa, Tomoaki
    Hara, Takuto
    Tobe, Taisuke
    Hirata, Junichiro
    Wakita, Naoto
    Okamura, Yasuyoshi
    Suzuki, Kotaro
    Bando, Yukari
    Chiba, Koji
    Teishima, Jun
    Nakano, Yuzo
    Miyake, Hideaki
    PROSTATE, 2024, 84 (16): : 1506 - 1514
  • [32] Molecular and Immunophenotypic Correlates of Metastatic Epithelioid Angiomyolipoma Include Alterations of TP53, RB1, and ATRX
    McCarthy, Michael R.
    Nichols, Paige E.
    Sharma, Vidit
    Stanton, Melissa L.
    Reynolds, Jordan P.
    Pitel, Beth A.
    Halling, Kevin C.
    Lohse, Christine M.
    Herrera-Hernandez, Loren
    Thompson, Houston
    Leibovich, Bradley C.
    Jimenez, Rafael E.
    Boorjian, Stephen A.
    Cheville, John C.
    Gupta, Sounak
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2023, 147 (07) : 817 - 825
  • [33] Concurrent RB1/TP53 Alterations in Targetable EGFRMutant Lung Adenocarcinoma Imply Aggressive Treatment
    Li, Y.
    Zhang, Y.
    Zhang, R.
    Nie, X.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S630 - S630
  • [34] Molecular and Immunophenotypic Correlates of Metastatic Epithelioid Angiomyolipoma Include Alterations of TP53, RB1 and ATRX
    McCarthy, Michael
    Jimenez, Rafael
    Hernandez, Loren Herrera
    Lohse, Christine
    Thompson, R. Houston
    Boorjian, Stephen
    Leibovich, Bradley
    Cheville, John
    Gupta, Sounak
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 634 - 634
  • [35] Genetic Alterations of Both MEN1/ATRX and TP53/RB1 in Pancreatic Neuroendocrine Neoplasms
    Zhang, Ming-Yi
    He, Du
    Zhang, Shuang
    Liu, Ji-Yan
    PANCREAS, 2022, 51 (06) : e91 - e93
  • [36] Molecular and Immunophenotypic Correlates of Metastatic Epithelioid Angiomyolipoma Include Alterations of TP53, RB1 and ATRX
    McCarthy, Michael
    Jimenez, Rafael
    Hernandez, Loren Herrera
    Lohse, Christine
    Thompson, R. Houston
    Boorjian, Stephen
    Leibovich, Bradley
    Cheville, John
    Gupta, Sounak
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 634 - 634
  • [37] Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation
    Harms, Paul W.
    Collie, Angela M. B.
    Hovelson, Daniel H.
    Cani, Andi K.
    Verhaegen, Monique E.
    Patel, Rajiv M.
    Fullen, Douglas R.
    Omata, Kei
    Dlugosz, Andrzej A.
    Tomlins, Scott A.
    Billings, Steven D.
    MODERN PATHOLOGY, 2016, 29 (03) : 240 - 248
  • [38] TP53 mutations in urothelial carcinoma: not all one and the same
    Barr, Alexis R.
    Burley, Amy
    Wilkins, Anna
    JOURNAL OF PATHOLOGY, 2024, 264 (02): : 125 - 128
  • [39] TP53 Germline Mutations in Adult Patients with Adrenocortical Carcinoma
    Herrmann, Leonie J. M.
    Heinze, Britta
    Fassnacht, Martin
    Willenberg, Holger S.
    Quinkler, Marcus
    Reisch, Nicole
    Zink, Martina
    Allolio, Bruno
    Hahner, Stefanie
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (03): : E476 - E485
  • [40] RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer
    Gonzalez Manzano, Ramon
    Catalan-Latorre, Ana
    Brugarolas, Antonio
    BMC CANCER, 2021, 21 (01)
12345